We also note that co-administration of EV-loaded miR-451a and let-7i-5p led to the significant reduction of the TLR4 dependent release CXCL10 (Supplemental Figure 5E), a biomarker of cerebral malaria severity (64). The gene discussed is TLR4; the disease is cerebral malaria.